Skip to Main Content

Paper Details

Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis.
J Rheumatol
6
2019
Anti-CCP-IgA, Anticyclic Citrullinated Peptide Antibodies 3, IgA, IgG/, OA, RA, Rheumatoid Arthritis, anti-CCP, anti-CCP-IgA, anti-CCP-IgG, anti-CCP3, anticyclic citrullinated peptide antibodies, osteoarthritis, patients, rheumatoid arthritis
Author NameAffiliation
Jane H BucknerUniversity of Colorado Anschutz Medical Campus, Colorado School of Public Health, University of Nebraska Medical Center, Cedars-Sinai Medical Center, Scripps Green Hospital, Benaroya Research Institute at Virginia Mason, Washington Center for Genomics and Human Genetics, Feinstein Institute for Medical Research
Jane H BucknerUniversity of Colorado Anschutz Medical Campus K.J. Polinski, Colorado School of Public Health T.R. Mikuls, University of Nebraska Medical Center, University of Colorado Anschutz Medical Campus J. August, University of Colorado Anschutz Medical Campus A. Visser, University of Colorado Anschutz Medical Campus M. Mahler, Cedars-Sinai Medical Center J.R. O'Dell, University of Nebraska Medical Center R.M. Keating, Scripps Green Hospital J.H. Buckner, Benaroya Research Institute at Virginia Mason P.K. Gregersen, Center for Genomics and Human Genetics, Feinstein Institute for Medical Research J.M. Norris, Colorado School of Public Health V.M. Holers, University of Colorado Anschutz Medical Campus K.D. Deane, University of Colorado Anschutz Medical Campus M.K. Demoruelle, University of Colorado Anschutz Medical Campus.
Peter K GregersenUniversity of Colorado Anschutz Medical Campus, Colorado School of Public Health, University of Nebraska Medical Center, Cedars-Sinai Medical Center, Scripps Green Hospital, Benaroya Research Institute at Virginia Mason, Washington Center for Genomics and Human Genetics, Feinstein Institute for Medical Research
Peter K GregersenUniversity of Colorado Anschutz Medical Campus K.J. Polinski, Colorado School of Public Health T.R. Mikuls, University of Nebraska Medical Center, University of Colorado Anschutz Medical Campus J. August, University of Colorado Anschutz Medical Campus A. Visser, University of Colorado Anschutz Medical Campus M. Mahler, Cedars-Sinai Medical Center J.R. O'Dell, University of Nebraska Medical Center R.M. Keating, Scripps Green Hospital J.H. Buckner, Benaroya Research Institute at Virginia Mason P.K. Gregersen, Center for Genomics and Human Genetics, Feinstein Institute for Medical Research J.M. Norris, Colorado School of Public Health V.M. Holers, University of Colorado Anschutz Medical Campus K.D. Deane, University of Colorado Anschutz Medical Campus M.K. Demoruelle, University of Colorado Anschutz Medical Campus.
Jill M NorrisUniversity of Colorado Anschutz Medical Campus, Colorado School of Public Health, University of Nebraska Medical Center, Cedars-Sinai Medical Center, Scripps Green Hospital, Benaroya Research Institute at Virginia Mason, Washington Center for Genomics and Human Genetics, Feinstein Institute for Medical Research
Jill M NorrisUniversity of Colorado Anschutz Medical Campus K.J. Polinski, Colorado School of Public Health T.R. Mikuls, University of Nebraska Medical Center, University of Colorado Anschutz Medical Campus J. August, University of Colorado Anschutz Medical Campus A. Visser, University of Colorado Anschutz Medical Campus M. Mahler, Cedars-Sinai Medical Center J.R. O'Dell, University of Nebraska Medical Center R.M. Keating, Scripps Green Hospital J.H. Buckner, Benaroya Research Institute at Virginia Mason P.K. Gregersen, Center for Genomics and Human Genetics, Feinstein Institute for Medical Research J.M. Norris, Colorado School of Public Health V.M. Holers, University of Colorado Anschutz Medical Campus K.D. Deane, University of Colorado Anschutz Medical Campus M.K. Demoruelle, University of Colorado Anschutz Medical Campus.
  • 1 - 6

Datasets

Release 1.2